| Q92113333 | 2019 EACTS Expert Consensus on long-term mechanical circulatory support |
| Q51750814 | Acquired von Willebrand Syndrome in Continuous-Flow Ventricular Assist Device Recipients |
| Q64236671 | Acquired von Willebrand Syndrome in Patients With Ventricular Assist Device |
| Q42925731 | Acquired von Willebrand Syndrome in Patients With an Axial Flow Left Ventricular Assist Device |
| Q37035825 | Acquired von Willebrand syndrome associated with left ventricular assist device |
| Q46984873 | Acquired von Willebrand syndrome in patients with extracorporeal life support (ECLS). |
| Q59404331 | Anesthetic management for abdominal aortic surgery in a patient with a left ventricular assist device: a case report |
| Q26770302 | Anticoagulation management in mechanical circulatory support |
| Q53463075 | Anticoagulation management of left ventricular assist devices. |
| Q38834342 | Association between cell-derived microparticles and adverse events in patients with nonpulsatile left ventricular assist devices |
| Q90034535 | Benchtop von Willebrand Factor Testing: Comparison of Commercially Available Ventricular Assist Devices and Evaluation of Variables for a Standardized Test Method |
| Q37899081 | Biventricular assist devices: a technical review. |
| Q37170282 | Bleeding and thrombosis in chronic ventricular assist device therapy: focus on platelets |
| Q42369262 | Bleeding in continuous flow left ventricular assist device recipients: an acquired vasculopathy? |
| Q42337826 | Bleeding with the artificial heart: Gastrointestinal hemorrhage in CF-LVAD patients |
| Q88325224 | Cerebrovascular Events After Continuous-Flow Left Ventricular Assist Devices |
| Q38015693 | Cerebrovascular complications of left ventricular assist devices |
| Q38845511 | Challenges faced in long term ventricular assist device support |
| Q50970967 | Characteristics of gastrointestinal bleeding after placement of continuous-flow left ventricular assist device: a case series. |
| Q38611535 | Coagulopathy in Mechanical Circulatory Support: A Fine Balance |
| Q33796456 | Computational fluid dynamics analysis to determine shear stresses and rates in a centrifugal left ventricular assist device |
| Q42041978 | Continuous flow left ventricular assist devices and gastrointestinal bleeding |
| Q53077712 | Corpus callosum hemorrhage during left ventricular-assist device support. |
| Q38870760 | Current status of mechanical circulatory support for treatment of advanced end-stage heart failure: successes, shortcomings and needs |
| Q24630052 | Devices in the management of advanced, chronic heart failure |
| Q30431630 | Early thrombus in a HeartMate II left ventricular assist device: a potential cause of hemolysis and diagnostic dilemma |
| Q36093132 | Effects of HeartWare ventricular assist device on the von Willebrand factor: results of an academic Belgian center |
| Q37672244 | Emerging ventricular assist devices for long-term cardiac support |
| Q35591937 | Endoscopic findings and clinical outcomes in ventricular assist device recipients with gastrointestinal bleeding |
| Q45465603 | Establishing a method for in vitro investigation of mechanical parameters causing acquired von Willebrand syndrome in ventricular assist devices. |
| Q51368551 | Evaluation of Four Veterinary Hematology Analyzers for Bovine and Ovine Blood Counts for In Vitro Testing of Medical Devices. |
| Q45802680 | Evaluation of platelet aggregability during left ventricular bypass using a MedTech MagLev VAD in a series of chronic calf experiments |
| Q38790056 | Gastrointestinal Bleeding Following LVAD Placement from Top to Bottom. |
| Q34498773 | Gastrointestinal bleed after left ventricular assist device implantation: incidence, management, and prevention |
| Q27007485 | Gastrointestinal bleeding after continuous-flow left ventricular device implantation: review of pathophysiology and management |
| Q30456938 | Gastrointestinal bleeding in patients with ventricular assist devices: what every cardiac nurse should know |
| Q37820972 | HeartMate® II continuous-flow left ventricular assist system |
| Q85019819 | Hematologic Effects of Continuous Flow Left Ventricular Assist Devices |
| Q94064186 | High Molecular Weight von Willebrand Factor Multimer Loss and Bleeding in Patients with Short-Term Mechanical Circulatory Support Devices: A Case Series |
| Q37838842 | Implantable mechanical circulatory support: demystifying patients with ventricular assist devices and artificial hearts. |
| Q46846191 | Intraplatelet reactive oxygen species, mitochondrial damage and platelet apoptosis augment non-surgical bleeding in heart failure patients supported by continuous-flow left ventricular assist device. |
| Q88711503 | Left Ventricular Assist Devices in the Management of Heart Failure |
| Q39136145 | Left ventricular assist device therapy in advanced heart failure: patient selection and outcomes |
| Q44929986 | Left ventricular assist device-induced coagulation and platelet activation and effect of the current anticoagulant therapy regimen |
| Q50987110 | Management of anticoagulation and antiplatelet therapy in patients with left ventricular assist devices. |
| Q38153202 | Management of patients with implanted ventricular assist devices for noncardiac surgery: a clinical review |
| Q43920468 | Mechanical Circulatory Support for Advanced Heart Failure |
| Q26747170 | Mechanical circulatory assist devices: a primer for critical care and emergency physicians |
| Q38276527 | Mechanical circulatory support devices as destination therapy-current evidence |
| Q38063908 | Mechanical circulatory support in 201--raising the bar or closing the door, for xenotransplantation? |
| Q39416821 | Mechanical circulatory support is associated with loss of platelet receptors glycoprotein Ibα and glycoprotein VI. |
| Q40273454 | Mechanistic insight of platelet apoptosis leading to non-surgical bleeding among heart failure patients supported by continuous-flow left ventricular assist devices |
| Q41512077 | Monitoring hemostasis parameters in left ventricular assist device recipients - a preliminary report |
| Q36082507 | Multicentre clinical trial experience with the HeartMate 3 left ventricular assist device: 30-day outcomes. |
| Q93166845 | Outcomes After Intracranial Hemorrhage in Patients with Left Ventricular Assist Devices: A Systematic Review of Literature |
| Q38081154 | Patient selection for cardiac transplant in 2012. |
| Q36289557 | Perioperative onset of acquired von Willebrand syndrome: Comparison between HVAD, HeartMate II and on-pump coronary bypass surgery |
| Q38612227 | Pharmacotherapeutic Management of Gastrointestinal Bleeding in Patients with Continuous-Flow Left-Ventricular Assist Devices |
| Q37826020 | Pharmacotherapy for mechanical circulatory support: a comprehensive review |
| Q41646222 | Platelet dysfunction and acquired von Willebrand syndrome in patients with left ventricular assist devices |
| Q37625884 | Platelet glycoprotein Ibα ectodomain shedding and non-surgical bleeding in heart failure patients supported by continuous-flow left ventricular assist devices. |
| Q36043689 | Quantification methods for human and large animal leukocytes using DNA dyes by flow cytometry |
| Q47577914 | Reviewing the use of ventricular assist devices in the elderly: where do we stand today? |
| Q58541812 | Small bowel bleeding in patients with left ventricular assist device: outcomes of conservative therapy versus balloon-assisted enteroscopy |
| Q37960332 | State-of-the-art implantable cardiac assist device therapy for heart failure: bridge to transplant and destination therapy |
| Q42131016 | The CentriMag centrifugal blood pump as a benchmark for in vitro testing of hemocompatibility in implantable ventricular assist devices. |
| Q50963821 | The Incidence, Predictors and Outcomes of Gastrointestinal Bleeding in Patients with Left Ventricular Assist Device (LVAD). |
| Q47435691 | The effect of shear stress on the size, structure, and function of human von Willebrand factor. |
| Q47689822 | The evaluation of leukocytes in response to the in vitro testing of ventricular assist devices. |
| Q34373693 | Trends in the use and outcomes of ventricular assist devices among medicare beneficiaries, 2006 through 2011. |
| Q84061449 | We always need a pulse, or do we?? |